Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
3 clinical trials · Condition
◉ Watch Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
| Record | Firm | Date |
|---|---|---|
| Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N (NCT06640725) | Groupe Oncologie Radiotherapie Tete et Cou | 2025-01-02 |
| A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (NCT04868162) | Shanghai Miracogen Inc. | 2021-04-23 |
| An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy. (NCT02145312) | Yonsei University | 2016-10-01 |
Track Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.